Author:
Masoud Mirzaie,Zaur Guliyev,Mohammed Dakna
Publisher
Heighten Science Publications Corporation
Reference37 articles.
1. 1. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, et al. ESC Committee for Practice Guidelines: ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32: 2851-2906. PubMed: https://pubmed.ncbi.nlm.nih.gov/21873417/
2. 2. Tsetis D, Belli AM. Guidelines for stenting in infrainguinal arterial disease. Cardiovasc Intervent Radiol. 2004; 27: 198-203. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15129334
3. 3. Gur I, Lee W, Akopian G, Rowe VL, Weaver FA, et al. Clinical outcomes and implications of failed infrainguinal endovascular stents. J Vasc Surg. 2011; 53: 658-666. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21257284
4. 4. Armstrong EJ, Saeed H, Alvandi B, Singh S, Singh GD, Yeo KK et al. Nitinol self-expanding stents vs. balloon angioplasty for very long femoropopliteal lesions. J Endovasc Ther. 2014; 21: 34-43. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24502482
5. 5. Cassese S, Byrne RA, Ott I, Ndrepepa G, Nerad M, et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials, Circ Cardiovasc Interv, 2012; 5: 582-589. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22851526